30 June 2020
Latham & Watkins Advises the Underwriters in Fusion Pharmaceuticals’ IPO
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Peter Handrinos Lead | Latham & Watkins LLP | Partner | capital markets | Not stated |
| Wesley Holmes Lead | Latham & Watkins LLP | Partner | capital markets | Not stated |
| Adam Johnson | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Angel Marcial | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Tyler Mills | Latham & Watkins LLP | Associate | capital markets | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 213m ($212.5 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Fusion Pharmaceuticals Inc. (Issuer)